Recent Finacing
Recent Raise
Elastrin Therapeutics develops elastin-targeted nanoparticle therapies, including ELT-001 (EDTA-loaded, anti-elastin antibody-conjugated albumin nanoparticles), to remove vascular calcification and restore degraded elastin.
